Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 24/05/20

Trade details

Type
Insider sale
Amount
$12,871.25
Shares · price
7,355 sh · $1.75 a share
Held after
257,670 sh
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Trade date
24/05/17
Filed
24/05/20
Days to filing
3 days

Sold 2.8% of holdings

Share of holding sold
2.8%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/17~24/06/16

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21